Topic

Retevmo (selpercatinib)

A collection of 24 issues

Do You Qualify for Retevmo (Selpercatinib) Coverage by UnitedHealthcare in Florida? Decision Tree & Next Steps

Quick Answer: Getting Retevmo (Selpercatinib) Covered by UnitedHealthcare in Florida You likely qualify for Retevmo coverage if you have RET fusion-positive cancer confirmed by FDA-approved testing and haven't responded to or can't tolerate standard treatments. UnitedHealthcare requires prior authorization through OptumRx. Submit via the UnitedHealthcare provider
6 min read

How to Get Retevmo (Selpercatinib) Covered by UnitedHealthcare in Virginia: Complete Prior Authorization and Appeals Guide

Answer Box: Getting Retevmo Covered by UnitedHealthcare in Virginia UnitedHealthcare requires prior authorization for Retevmo (selpercatinib) with RET alteration testing via FDA-approved diagnostics like FoundationOne CDx. The fastest path: (1) Gather RET fusion/mutation test results and complete pathology reports, (2) Submit PA through UnitedHealthcare Provider Portal with oncology consultation
5 min read

Renewing Retevmo (Selpercatinib) Approval with Cigna in Virginia: Complete Renewal Guide and Timeline

Answer Box: Retevmo (Selpercatinib) Renewal with Cigna in Virginia Cigna requires prior authorization renewal for Retevmo (selpercatinib) every 12 months through Express Scripts/Accredo specialty pharmacy. Start your renewal 30-45 days before expiration with updated RET testing confirmation, disease status imaging, treatment response documentation, and an oncologist necessity letter citing
5 min read

How to Get Retevmo (Selpercatinib) Covered by Cigna in Washington: Complete Prior Authorization and Appeals Guide

Answer Box: Getting Retevmo (Selpercatinib) Covered by Cigna in Washington Cigna requires prior authorization for Retevmo (selpercatinib) for RET fusion-positive NSCLC and RET-altered thyroid cancers. Key requirements: FDA-approved RET test results, advanced/metastatic disease documentation, and NCCN-aligned medical necessity. If denied, Washington residents can use internal appeals (180-day deadline) followed
5 min read

How to Get Retevmo (Selpercatinib) Covered by Blue Cross Blue Shield in North Carolina: Complete Prior Authorization and Appeals Guide

Quick Answer: Getting Retevmo Covered by BCBS North Carolina Blue Cross Blue Shield of North Carolina requires prior authorization for Retevmo (selpercatinib) for RET fusion-positive NSCLC and thyroid cancers. You'll need FDA-approved RET testing results, pathology reports, and clinical documentation. If denied, file internal appeals within 180 days,
5 min read

How to Get Retevmo (Selpercatinib) Covered by Humana in Illinois: Complete Prior Authorization and Appeals Guide

Answer Box: Getting Retevmo (Selpercatinib) Covered by Humana in Illinois Retevmo requires prior authorization from Humana and is typically non-formulary, requiring a formulary exception request. The fastest path to approval: 1) Confirm RET alteration with FDA-approved genetic testing, 2) Have your oncologist submit a comprehensive prior authorization through Humana'
5 min read